Valuation: Navamedic ASA

Market Cap 373M 40.09M 34.34M 32.13M 29.41M 55.2M 3.84B 55.93M 380M 148M 1.93B 151M 147M 6.37B P/E 2026 *
-51.3x
P/E 2027 * 49.8x
Enterprise Value 511M 54.98M 47.09M 44.06M 40.33M 75.7M 5.26B 76.7M 521M 203M 2.64B 206M 202M 8.74B EV / Sales 2026 *
0.89x
EV / Sales 2027 * 0.8x
Free-Float
30.82%
Yield 2026 *
-
Yield 2027 * -
1 day+0.65%
1 week-6.33%
Current month-6.33%
1 month-3.72%
3 months-14.09%
6 months-25.95%
Current year-34.66%
1 week 15.1
Extreme 15.1
16.95
1 month 15.1
Extreme 15.1
17.95
Current year 15.1
Extreme 15.1
24.5
1 year 15.1
Extreme 15.1
26.5
3 years 15.1
Extreme 15.1
43.9
5 years 15.1
Extreme 15.1
43.9
10 years 8.5
Extreme 8.5
43.9
Manager TitleAgeSince
Chief Executive Officer 55 18/06/2026
Director of Finance/CFO - 01/01/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 54 01/06/2022
Director/Board Member - 01/06/2023
Director/Board Member 60 01/06/2024
Date Insider Type Main position Quantity % Market Cap.
19/12/24 Buy

Chief Operating Officer

10,267 0.0581%
9/9/24 Fiscal year

Chief Executive Officer

80,000 0.4589%
9/9/24 Fiscal year

Chief Operating Officer

75,000 0.4302%
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%-6.33%-30.58%-51.86% 40.09M
+0.88%+6.38%+76.40%+126.75% 1,119B
+1.07%+3.80%+50.73%+62.78% 651B
+1.20%+6.21%+25.81%+78.74% 468B
+1.02%+5.77%+43.63%+48.43% 374B
+0.85%+4.07%+24.97%+40.58% 302B
+1.26%+6.81%+2.27%+14.41% 259B
+1.88%+5.81%+49.57%+70.53% 238B
+1.59%+2.09%-17.33%-52.62% 208B
+1.87%+5.61%+27.32%+91.38% 181B
Average +1.23%+3.84%+25.28%+42.91% 379.99B
Weighted average by Cap. +1.14%+5.09%+44.26%+72.65%

Financials

2026 *2027 *
Net sales 574M 61.74M 52.89M 49.48M 45.3M 85.01M 5.91B 86.13M 585M 228M 2.97B 232M 227M 9.82B 610M 65.57M 56.17M 52.55M 48.11M 90.28M 6.27B 91.47M 621M 242M 3.15B 246M 241M 10.42B
Net income -7.5M -806K -690K -646K -591K -1.11M -77.1M -1.12M -7.63M -2.98M -38.73M -3.03M -2.96M -128M 7.7M 827K 709K 663K 607K 1.14M 79.17M 1.15M 7.84M 3.06M 39.77M 3.11M 3.04M 132M
Net Debt 138M 14.89M 12.75M 11.93M 10.92M 20.5M 1.42B 20.77M 141M 54.98M 716M 55.91M 54.69M 2.37B 115M 12.35M 10.58M 9.9M 9.06M 17.01M 1.18B 17.23M 117M 45.61M 594M 46.38M 45.37M 1.96B
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
21/08/26 NOK 15.55 +0.65% 6,295
20/08/26 NOK 15.45 -1.90% 31,505
19/08/26 NOK 15.75 -0.63% 19,488
18/08/26 NOK 15.85 -2.46% 61,007
17/08/26 NOK 16.25 -2.11% 22,962
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
15.55NOK
Average target price
21.00NOK
Spread / Average Target
+35.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock